Pilot Study of Cognitive Behavioral Therapy-Informed Physical Therapy Intervention in Functional Neurological Disorders
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03731078|
Recruitment Status : Recruiting
First Posted : November 6, 2018
Last Update Posted : March 11, 2019
Functional Neurological Disorder (FND/ Conversion Disorder) is a highly prevalent and disabling neuropsychiatric condition. Motor FND symptoms include Functional Movement Disorders (FMD) and Functional Weakness and Psychogenic Nonepileptic Seizures (PNES).Though patients with FND present with a wide variety of symptoms, FMD, PNES, and functional weakness may be viewed as overlapping conditions lying along a phenotypic spectrum for a single disorder. Patients with FND frequently present with psychiatric symptoms, including depression, anxiety, Borderline Personality Disorder, and Post-Traumatic Stress Disorder, alongside their physical symptoms. To treat these symptoms, patients with FND are frequently enrolled in physical therapy and cognitive behavioral therapy, which are considered usual care for FND at our center. Developing a further understanding of treatment outcome, including biomarkers of clinical improvement and psychometric factors associated with treatment response, could inform future interventions and better tailor treatments to patients with specific FND symptom profiles.
We hypothesize that treatment response will be associated with structural and functional alterations in salience network regions and that more adaptive neuropsychiatric profiles at baseline will predict a positive treatment outcome.
|Condition or disease||Intervention/treatment|
|Functional Neurological Disorder||Other: CBT Informed physical therapy Intervention|
Show Detailed Description
|Study Type :||Observational|
|Estimated Enrollment :||70 participants|
|Official Title:||Pilot Study of Cognitive Behavioral Therapy-Informed Physical Therapy Intervention in Functional Neurological Disorders|
|Estimated Study Start Date :||March 8, 2019|
|Estimated Primary Completion Date :||January 2, 2024|
|Estimated Study Completion Date :||January 2, 2024|
Motor Functional Neurological Disorder
The cohort will consist of patients with clinically-established motor functional neurological disorder, which includes individuals with functional movement disorders and functional limb weakness. Individuals with functional movement disorders and/or functional limb weakness who also have psychogenic nonepileptic seizures will be included. Patients will receive CBT informed PT intervention. The physical therapy intervention will be usual care in FND and based on consensus recommendations, clinical trials and good practices.
Other: CBT Informed physical therapy Intervention
The 12 physical therapy sessions delivered in Massachusetts General Hospital outpatient physical therapy sites sessions include:1) evaluation and education; 2) strategy identification and goal setting; 3) functional strengthening part one; 4) functional strengthening part two; 5) pre-gait activities with distraction; 6) gait training with distraction and use of strategies; 7) minimizing tremor with use of strategies; 8) higher level balance training; 9) functional reintegration part one; 10) functional reintegration part two; 11) identification of strategies to limit recurrence; 12) education for relapse prevention.Patients will also be given and asked to complete the self-guided CBT workbookL Overcoming Functional Neurological Symptoms: A Five Area Approach. They will be asked to complete the first two chapters over the first 4 weeks and the remaining 8 chapters over the following 8 weeks.
- Short Form Health Survery 36 (SF-36) [ Time Frame: 1-5 years ]questionnaire to identify change in health-related quality of life post vs. pre-treatment
- Screening for Somatoform Symptoms Conversion Disorder subscale (SOMS:CD) [ Time Frame: 1-5 years ]composite score post vs. pre-treatment
- Patient Health Questionnaire-15 (PHQ-15) [ Time Frame: 1-5 years ]composite score post vs. pre-treatment
- Clinical Global Impressions (CGI) - clinician rated scale [ Time Frame: 1-5 years ]clinical global impression of improvement as rated by clinician
- Clinical Global Impressions (CGI) - patient rated [ Time Frame: 1-5 years ]clinical global impression of improvement as rated by patient
- 10meter walk test [ Time Frame: 1-5 years ]change in post vs. pre-treatment speed of walking at preferred pace
- Five Times Sit to Stand test [ Time Frame: 1-5 years ]change in post vs. pre-treatment time to move from sitting to standing five times
- Simplified Functional Movement Disorders Rating Scale (S-FMDRS) [ Time Frame: 1-5 years ]clinician rated functional neurological symptom severity scale
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03731078
|Contact: David L Perez, MD, MMScfirstname.lastname@example.org|
|Contact: Julie B Maggio, PT, DPT, NCSemail@example.com|
|United States, Massachusetts|
|Massachusetts General Hospital||Recruiting|
|Boston, Massachusetts, United States, 02114|
|Contact: David L Perez, MD, MMSc 617-724-7243 firstname.lastname@example.org|
|Principal Investigator:||David L Perez, MD, MMSc||Massachusetts General Hospital|